NCT00003076View on ClinicalTrials.gov

Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus

PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 31, 1995

Primary Completion Date

June 30, 2002

Study Completion Date

October 31, 2005

Conditions
Esophageal Cancer
Interventions
DRUG

eflornithine

Trial Locations (5)

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

70112

Tulane University School of Medicine, New Orleans

75216

Veterans Affairs Medical Center - Dallas, Dallas

02114

Massachusetts General Hospital Cancer Center, Boston

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER